341 related articles for article (PubMed ID: 29376861)
1. The Progression of Neuropsychiatric Symptoms in Alzheimer's Disease During a Five-Year Follow-Up: Kuopio ALSOVA Study.
Hallikainen I; Hongisto K; Välimäki T; Hänninen T; Martikainen J; Koivisto AM
J Alzheimers Dis; 2018; 61(4):1367-1376. PubMed ID: 29376861
[TBL] [Abstract][Full Text] [Related]
2. Quality of Life in relation to neuropsychiatric symptoms in Alzheimer's disease: 5-year prospective ALSOVA cohort study.
Hongisto K; Hallikainen I; Selander T; Törmälehto S; Väätäinen S; Martikainen J; Välimäki T; Hartikainen S; Suhonen J; Koivisto AM
Int J Geriatr Psychiatry; 2018 Jan; 33(1):47-57. PubMed ID: 28067961
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric symptoms and activities of daily living in Alzheimer's disease: ALSOVA 5-year follow-up study.
Saari T; Hallikainen I; Hintsa T; Koivisto AM
Int Psychogeriatr; 2020 Jun; 32(6):741-751. PubMed ID: 31656211
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.
Dietlin S; Soto M; Kiyasova V; Pueyo M; de Mauleon A; Delrieu J; Ousset PJ; Vellas B
J Alzheimers Dis; 2019; 70(1):25-34. PubMed ID: 31127783
[TBL] [Abstract][Full Text] [Related]
5. The course of neuropsychiatric symptoms in dementia: a 3-year longitudinal study.
Brodaty H; Connors MH; Xu J; Woodward M; Ames D;
J Am Med Dir Assoc; 2015 May; 16(5):380-7. PubMed ID: 25687925
[TBL] [Abstract][Full Text] [Related]
6. Use of psychotropic medications in relation to neuropsychiatric symptoms, cognition and functional performance in Alzheimer's disease over a three-year period: Kuopio ALSOVA study.
Törmälehto S; Martikainen J; Bell JS; Hallikainen I; Koivisto AM
Int Psychogeriatr; 2017 Oct; 29(10):1723-1733. PubMed ID: 28625207
[TBL] [Abstract][Full Text] [Related]
7. Delusions in Patients with Alzheimer's Disease: A Multidimensional Approach.
D'Onofrio G; Panza F; Sancarlo D; Paris FF; Cascavilla L; Mangiacotti A; Lauriola M; Paroni GH; Seripa D; Greco A
J Alzheimers Dis; 2016; 51(2):427-37. PubMed ID: 26890768
[TBL] [Abstract][Full Text] [Related]
8. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis.
Zhao QF; Tan L; Wang HF; Jiang T; Tan MS; Tan L; Xu W; Li JQ; Wang J; Lai TJ; Yu JT
J Affect Disord; 2016 Jan; 190():264-271. PubMed ID: 26540080
[TBL] [Abstract][Full Text] [Related]
10. Behavioral and psychological symptoms in Alzheimer's disease: frequency and relationship with duration and severity of the disease.
Piccininni M; Di Carlo A; Baldereschi M; Zaccara G; Inzitari D
Dement Geriatr Cogn Disord; 2005; 19(5-6):276-81. PubMed ID: 15775717
[TBL] [Abstract][Full Text] [Related]
11. Caregiver report versus clinician impression: disagreements in rating neuropsychiatric symptoms in Alzheimer's disease patients.
Stella F; Forlenza OV; Laks J; de Andrade LP; de Castilho Cação J; Govone JS; de Medeiros K; Lyketsos CG
Int J Geriatr Psychiatry; 2015 Dec; 30(12):1230-7. PubMed ID: 25754669
[TBL] [Abstract][Full Text] [Related]
12. Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients.
Shimabukuro J; Awata S; Matsuoka H
Psychiatry Clin Neurosci; 2005 Jun; 59(3):274-9. PubMed ID: 15896220
[TBL] [Abstract][Full Text] [Related]
13. Early psychosocial intervention does not delay institutionalization in persons with mild Alzheimer disease and has impact on neither disease progression nor caregivers' well-being: ALSOVA 3-year follow-up.
Koivisto AM; Hallikainen I; Välimäki T; Hongisto K; Hiltunen A; Karppi P; Sivenius J; Soininen H; Martikainen J
Int J Geriatr Psychiatry; 2016 Mar; 31(3):273-83. PubMed ID: 26177825
[TBL] [Abstract][Full Text] [Related]
14. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
[TBL] [Abstract][Full Text] [Related]
15. Relationship between dementia severity and behavioural and psychological symptoms in early-onset Alzheimer's disease.
Tanaka H; Hashimoto M; Fukuhara R; Ishikawa T; Yatabe Y; Kaneda K; Yuuki S; Honda K; Matsuzaki S; Tsuyuguchi A; Hatada Y; Ikeda M
Psychogeriatrics; 2015 Dec; 15(4):242-7. PubMed ID: 25737233
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease.
Karttunen K; Karppi P; Hiltunen A; Vanhanen M; Välimäki T; Martikainen J; Valtonen H; Sivenius J; Soininen H; Hartikainen S; Suhonen J; Pirttilä T;
Int J Geriatr Psychiatry; 2011 May; 26(5):473-82. PubMed ID: 21445998
[TBL] [Abstract][Full Text] [Related]
17. Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.
Törmälehto SM; Martikainen JA; Väätäinen ST; Hallikainen IT; Hallikainen M; Bell JS; Koivisto AM
J Alzheimers Dis; 2015; 48(4):1033-41. PubMed ID: 26444756
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric Symptoms of Alzheimer's Disease in Down Syndrome and Its Impact on Caregiver Distress.
Fonseca LM; Mattar GP; Haddad GG; Burduli E; McPherson SM; Guilhoto LMFF; Yassuda MS; Busatto GF; Bottino CMC; Hoexter MQ; Chaytor NS
J Alzheimers Dis; 2021; 81(1):137-154. PubMed ID: 33749644
[TBL] [Abstract][Full Text] [Related]
19. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
[TBL] [Abstract][Full Text] [Related]
20. Persistence of and changes in neuropsychiatric symptoms in Alzheimer disease over 6 months: the LASER-AD study.
Ryu SH; Katona C; Rive B; Livingston G
Am J Geriatr Psychiatry; 2005 Nov; 13(11):976-83. PubMed ID: 16286441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
